CMAR_A_201610 6379..6396

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2018

  2018cited by this paper
• Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis

  2016cited by this paper
• Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.

  2016cited by this paper
• Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

  2015cited by this paper
• Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia

  2015cited by this paper
• Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues.

  2015cited by this paper
• Whole genomes redefine the mutational landscape of pancreatic cancer

  2015cited by this paper
• Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk

  2014cited by this paper
• Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.

  2014cited by this paper
• Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis

  2014cited by this paper
• RETROSPECTIVE STUDY DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer

  2014cited by this paper
• The de novo DNA methyltransferase DNMT3A in development and cancer

  2014cited by this paper
• SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer

  2014cited by this paper
• Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer

  2014cited by this paper
• Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes

  2013cited by this paper
• DNA Methylation Pattern as Important Epigenetic Criterion in Cancer

  2013cited by this paper
• The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• DNA methylation data analysis and its application to cancer research.

  2013cited by this paper
• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  2012cited by this paper
• Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma

  2012cited by this paper
• Crystal structure of human protein tyrosine phosphatase SHP‐1 in the open conformation

  2011cited by this paper
• Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer

  2011cited by this paper
• Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.

  2011cited by this paper
• Regulation of NF-kappaB responses by epigenetic suppression of IkappaBalpha expression in HCT116 intestinal epithelial cells.

  2010cited by this paper
• DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL‐mediated apoptosis via up‐regulation of TRAIL‐R2/DR5 and caspase‐8

  2010cited by this paper
• Depletion of DNMT3A Suppressed Cell Proliferation and Restored PTEN in Hepatocellular Carcinoma Cell

  2010cited by this paper
• Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

  2010cited by this paper
• An essential role for DNA methyltransferase 3a in melanoma tumorigenesis.

  2009cited by this paper
• Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling

  2009cited by this paper
• Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial

  2008cited by this paper
• Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial

  2008cited by this paper
• CpG island methylation profile of pancreatic intraepithelial neoplasia

  2008cited by this paper
• JAK-STAT Signaling: From Interferons to Cytokines*

  2007cited by this paper
• Cancer genetics of epigenetic genes.

  2007cited by this paper
• Epigenetics: Perceptive enzymes

  2007cited by this paper
• The role of DNA methylation in cancer development.

  2006cited by this paper
• Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

  2006influential reference
• The Histone Methyltransferase SETDB1 and the DNA Methyltransferase DNMT3A Interact Directly and Localize to Promoters Silenced in Cancer Cells*

  2006cited by this paper
• Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas

  2005cited by this paper
• Epigenetic inactivation of SOCS‐1 by CpG island hypermethylation in human gastric carcinoma

  2004cited by this paper
• Signaling through the JAK/STAT pathway, recent advances and future challenges.

  2002cited by this paper
• DNA methylation, methyltransferases, and cancer

  2001cited by this paper
• SOCS Proteins: Negative Regulators of Cytokine Signaling

  2001cited by this paper
• Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases

  1998cited by this paper
• Specific inhibition of Stat3 signal transduction by PIAS3.

  1997cited by this paper

• No citing papers are available for this paper.